-
Signature
-
/s/ Alan Baratz
-
Issuer symbol
-
QBTS
-
Transactions as of
-
22 Dec 2025
-
Transactions value $
-
-$23,913,114
-
Form type
-
4
-
Filing time
-
23 Dec 2025, 16:16:50 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| BARATZ ALAN E |
President & CEO, Director |
2650 EAST BAYSHORE ROAD, PALO ALTO |
/s/ Alan Baratz |
23 Dec 2025 |
0001098231 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
QBTS |
Common Stock, par value $0.0001 per share ("Common Stock") |
Options Exercise |
$722K |
+794K |
+30.14% |
$0.91 |
3.43M |
22 Dec 2025 |
Direct |
F1, F2 |
| transaction |
QBTS |
Common Stock, par value $0.0001 per share ("Common Stock") |
Sale |
-$23.9M |
-794K |
-23.16% |
$30.13 |
2.63M |
22 Dec 2025 |
Direct |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
QBTS |
Stock Option (right to buy) |
Options Exercise |
-$722K |
-794K |
-62.59% |
$0.91 |
474K |
22 Dec 2025 |
Common Stock, par value $0.0001 per share ("Common Stock") |
794K |
$0.91 |
Direct |
F1, F4 |
| holding |
QBTS |
Stock Option (right to buy) |
|
|
|
|
|
213K |
22 Dec 2025 |
Common Stock, par value $0.0001 per share ("Common Stock") |
213K |
$0.85 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: